STAT

Before a biotech stock debacle, one Republican congressman made a prescient trade

Rep. John Culberson made a prescient sale to avoid losses when a tiny biotech's stock tanked. The stock was a favorite of several GOP representatives.
Rep. John Culberson made a prescient sale to avoid losses when a tiny biotech company's stock tanked.

A biotech stock meltdown last week led to huge paper losses for several congressional Republicans who had bought into the tiny company. But one politician-turned-investor was spared. Turns out, he had sold his shares just two weeks before news of a negative clinical trial decimated the company’s value.

Rep. John Culberson of Houston was among a half dozen House Republicans to invest in Innate Immunotherapeutics, an obscure Australian biotech company repeatedly

You're reading a preview, sign up to read more.

More from STAT

STAT3 min readSociety
Opinion: Has Your Insurer Denied A Medical Claim? Stand Up For Your Rights
Not appealing a denied medical insurance claim is a lost opportunity. Exercising your right to appeal often pays off.
STAT3 min read
Scott Gottlieb Is Skeptical Of The Science Behind CBD Supplements
D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox. When I chatted with the former FDA commissioner about the agency’s efforts to regulate CBD, one thing was cryst
STAT2 min read
Departure Of Top Haven Executive Creates Void At A Crucial Stage
Jack Stoddard left Haven after eight months as COO of the company founded by Amazon, Berkshire Hathaway, and JPMorgan Chase.